| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Deep-pocketed investors have adopted a bullish approach towards Zoetis (NYSE:ZTS), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ZTS usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 32 extraordinary options activities for Zoetis. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 53% leaning bullish and 46% bearish. Among these notable options, 29 are puts, totaling $2,964,129, and 3 are calls, amounting to $203,516.
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $115.0 to $175.0 for Zoetis over the last 3 months.
In terms of liquidity and interest, the mean open interest for Zoetis options trades today is 1858.23 with a total volume of 12,593.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Zoetis's big money trades within a strike price range of $115.0 to $175.0 over the last 30 days.
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZTS | PUT | TRADE | BEARISH | 07/19/24 | $21.0 | $19.2 | $21.0 | $170.00 | $1.0M | 727 | 500 |
| ZTS | PUT | TRADE | BEARISH | 07/19/24 | $21.9 | $19.4 | $21.0 | $170.00 | $392.7K | 727 | 500 |
| ZTS | PUT | TRADE | BULLISH | 04/19/24 | $4.8 | $3.4 | $3.5 | $150.00 | $210.0K | 3.2K | 1.0K |
| ZTS | PUT | SWEEP | BEARISH | 04/19/24 | $3.6 | $3.1 | $3.5 | $150.00 | $185.8K | 3.2K | 1.3K |
| ZTS | CALL | SWEEP | BULLISH | 05/17/24 | $4.5 | $4.2 | $4.5 | $155.00 | $104.1K | 178 | 252 |
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
1 market experts have recently issued ratings for this stock, with a consensus target price of $195.0.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Zoetis options trades with real-time alerts from Benzinga Pro.
Posted In: ZTS
